Cancer of the ovary, fallopian tube, and peritoneum

被引：86
作者：
Berek, Jonathan S. [1 ]
Crum, Christopher [2 ]
Friedlander, Michael [3 ]
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford Womens Canc Ctr, Stanford, CA 94305 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA
[3] Royal Hosp Women, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2012年 / 119卷
关键词：
GERM-CELL TUMORS; PHASE-III TRIAL; RECURRENT EPITHELIAL OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; SECONDARY CYTOREDUCTIVE SURGERY; PACLITAXEL-BASED CHEMOTHERAPY; TERM-FOLLOW-UP; STAGE-III; INTRAPERITONEAL CISPLATIN; INTRAEPITHELIAL CARCINOMA;
D O I：
10.1016/S0020-7292(12)60025-3
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：S118 / S129
页数：12
相关论文
共 107 条
  • [31] Long-term follow-up of women with ovarian cancer after positive second-look laparotomy
    Dowdy, SC
    Constantinou, CL
    Hartmann, LC
    Keeney, GL
    Suman, VJ
    Hillman, DW
    Podratz, KC
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 563 - 568
  • [32] Edge SB., 2010, AJCC CANC STAGING MA
  • [33] A phase II study of Gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
    Friedlander, M
    Millward, MJ
    Bell, D
    Bugat, R
    Harnett, P
    Moreno, JA
    Campbell, L
    Varette, C
    Ripoche, V
    Kayitalire, L
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (12) : 1343 - 1345
  • [34] Clinical Trials in Recurrent Ovarian Cancer
    Friedlander, Michael
    Trimble, Edward
    Tinker, Anna
    Alberts, David
    Avall-Lundqvist, Elisabeth
    Brady, Mark
    Harter, Philipp
    Pignata, Sandro
    Pujade-Lauraine, Eric
    Sehouli, Jalid
    Vergote, Ignace
    Beale, Philip
    Bekkers, Rudd
    Calvert, Paula
    Copeland, Lawrence
    Glasspool, Ros
    Gonzalez-Martin, Antonio
    Katsaros, Dionysis
    Kim, Jae Won
    Miller, Brigitte
    Provencher, Diane
    Rubinstein, Lawrence
    Atri, Mostafa
    Zeimet, Alain
    Bacon, Monica
    Kitchener, Henry
    Stuart, Gavin C. E.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) : 771 - 775
  • [35] Symptom Control in Patients With Recurrent Ovarian Cancer Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer
    Friedlander, Michael
    Butow, Phyllis
    Stockler, Martin
    Gainford, Corona
    Martyn, Julie
    Oza, Amit
    Donovan, Heidi S.
    Miller, Brigitte
    King, Madeline
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 : S44 - S48
  • [36] Paclitaxel-based chemotherapy in carcinoma of the Fallopian tube
    Gemignani, ML
    Hensley, ML
    Cohen, R
    Venkatraman, E
    Saigo, PE
    Barakat, RR
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 80 (01) : 16 - 20
  • [37] TREATMENT OF MALIGNANT GERM-CELL TUMORS OF THE OVARY WITH BLEOMYCIN, ETOPOSIDE, AND CISPLATIN
    GERSHENSON, DM
    MORRIS, M
    CANGIR, A
    KAVANAGH, JJ
    STRINGER, CA
    EDWARDS, CL
    SILVA, EG
    WHARTON, JT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) : 715 - 720
  • [38] Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan
    Gordon, AN
    Fleagle, JT
    Guthrie, D
    Parkin, DE
    Gore, ME
    Lacave, AJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) : 3312 - 3322
  • [39] HACKER NF, 1983, OBSTET GYNECOL, V61, P413
  • [40] ORAL ETOPOSIDE IS ACTIVE AGAINST PLATINUM-RESISTANT EPITHELIAL OVARIAN-CANCER
    HOSKINS, PJ
    SWENERTON, KD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 60 - 63
12345678910